Using 5-deoxy-5-[ 18 F]fluororibose to glycosylate peptides for positron emission tomography

Nature Protocols

Volumn 9, Issue 1, 2014, Pages 138-145

  Li, Xiang Guo ^a   Helariutta, Kerttuli ^b   Roivainen, Anne ^a,c   Jalkanen, Sirpa ^d   Knuuti, Juhani ^a   Airaksinen, Anu J ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; METHYLAMINE;

ANION EXCHANGE; ARTICLE; CATALYSIS; CLINICAL PROTOCOL; FLUORINATION; HYDROLYSIS; HYDROPHILICITY; IN VIVO STUDY; LIPOPHILICITY; PH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORINE RADIOISOTOPES; GLYCOSYLATION; HALOGENATION; ISOTOPE LABELING; POSITRON-EMISSION TOMOGRAPHY; RIBOSE;

EID: 84891681231     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2013.170     Document Type: Article

References (62)

1. Ametamey, S.M., Honer, M. &Schubiger, P.A. Molecular imaging with PET. Chem. Rev. 108, 1501-1516 (2008)
2. Tredwell, M. &Gouverneur, V. 18F-Labeling of arenes. Angew. Chem. Int. Ed. 51, 11426-11437 (2012)
3. Holland, J.P., Cumming, P. &Vasdev, N. PET imaging of signal transduction pathways in cancer. J. Nucl. Med. 53, 1333-1336 (2012)
4. Aalto, K. et al. Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. Blood 118, 3725-3733 (2011)
5. Koopmans, K.P. &Glaudemans, A.W.J.M. Rationale for the use of radiolabeled peptides in diagnosis and therapy. Eur. J. Nucl. Med. Mol. Imaging 39 (suppl. 1): S4-S10 (2012)
6. Roivainen, A., Jalkanen, S. &Nanni, C. Gallium-labeled peptides for imaging of inflammation. Eur. J. Nucl. Med. Mol. Imaging 39 (suppl. 1): S68-S77 (2012)
7. Kostikov, A.P. et al. Synthesis of [18F]SiFB: a prosthetic group for direct protein radiolabeling for application in positron emission tomography. Nat. Protoc. 7, 1956-1963 (2012)
8. Wngler, C. et al. One-step 18F-labeling of peptides for positron emission tomography imaging using the SiFA methodology. Nat. Protoc. 7, 1946-1954 (2012)
9. Gill, H.S. &Marik, J. Preparation of 18F-labeled peptides using the copper (I)-catalyzed azide-Alkyne 1,3-dipolar cycloaddition. Nat. Protoc. 6, 1718-1725 (2011)
10. Saha, G.B. Basics of PET Imaging: Physics, Chemistry and Regulations 2nd edn. (Springer, 2010)
11. Miller, P.W., Long, N.J., Vilar, R. &Gee, A.D. Synthesis of 11C, 18F, 15O, and 13C radiolabels for positron emission tomography. Angew. Chem. Int. Ed. 47, 8998-9033 (2008)
12. Li, X.-G. et al. Translating the concept of peptide labeling with 5-deoxy-5-[18F]fluororibose into preclinical practice: 18F-labeling of Siglec-9 peptide for PET imaging of inflammation. Chem. Commun. 49, 3682-3684 (2013)
13. Hermanson, G.T. Bioconjugate Techniques 2nd edn. (Elsevier, 2008)
14. Zeng, Y., Ramya, T.N.C., Dirksen, A., Dawson, P.E. &Paulson, J.C. High-efficiency labeling of sialylated glycoproteins on living cells. Nat. Methods 6, 207-209 (2009)
15. Rashidian, M., Song, J.M., Pricer, R.E. &Distefano, M.D. Chemoenzymatic reversible immobilization and labeling of proteins without prior purification. J. Am. Chem. Soc. 134, 8455-8467 (2012)
16. Schottelius, M. et al. First 18F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin. Cancer Res. 10, 3593-3606 (2004)
17. OHagan, D. &Li, X.-G. Labeling method in preparation of 5-, 3- or 2-18F-deoxypentose conjugated with biological active molecules useful for PET imaging. British patent application no. 2491950 2011.
18. Li, X.-G., Haaparanta, M. &Solin, O. Oxime formation for fluorine-18 labeling of peptides and proteins for positron emission tomography (PET) imaging: a review. J. Fluorine Chem. 143, 49-56 (2012)
19. Li, X.-G., DallAngelo, S., Schweiger, L.F., Zanda, M. &OHagan, D. [18F]-5-Fluoro-5-deoxyribose, an efficient peptide bioconjugation ligand for positron emission tomography (PET) imaging. Chem. Commun. 48, 5247-5249 (2012)
20. Dirksen, A., Hackeng, T.M. &Dawson, P.E. Nucleophilic catalysis of oxime ether ligation. Angew. Chem. 118, 7743-7746 (2006)
21. Rayo, J., Amara, N., Krief, P. &Meijler, M.M. Live cell labeling of native intracellular bacterial receptors using aniline-catalyzed oxime ether ligation. J. Am. Chem. Soc. 133, 7469-7475 (2011)
22. Kohler, J.J. Aniline: a catalyst for sialic acid detection. ChemBioChem 10, 2147-2150 (2009)
23. Liu, Z. et al. Stoichiometric leverage: rapid 18F-Aryltrifluoroborate radiosynthesis at high specific activity for click conjugation. Angew. Chem. Int. Ed. 52, 2303-2307 (2013)
24. Mller-Platz, C.M., Kloster, G., Legler, G. &Stcklin, G. 18F-Fluoroacetate: an agent for introducing no-carrier added fluorine-18 into urokinase without loss of biological activity. J. Label. Compd. Radiopharm. 19, 1645-1646 (1982)
25. Tolmachev, V. &Orlova, A. Influence of labeling methods on biodistribution and imaging properties of radiolabeled peptides for visualisation of molecular therapeutic targets. Curr. Med. Chem. 17, 2636-2655 (2010)
26. Gaertner, F.C., Kessler, H., Wester, H.-J., Schwaiger, M. &Beer, A.J. Radiolabeled RGD peptides for imaging and therapy. Eur. J. Nucl. Med. Mol. Imaging 39 (suppl. 1): S126-S138 (2012)
27. Fani, M. et al. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference. J. Nucl. Med. 52, 1110-1118 (2011)
28. Beer, A.J. et al. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin ?v?3 expression in man. Clin. Cancer Res. 12, 3942-3949 (2006)
29. Haubner, R. et al. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjug. Chem. 15, 61-69 (2004)
30. Wester, H.-J. et al. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labeled, carbohydrate analogue of octreotide. Eur. J. Nucl. Med. Mol. Imaging 30, 117-122 (2003)
31. Meisetschlger, G. et al. Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-Octreotide. J. Nucl. Med. 47, 566-573 (2006)
32. Wieder, H. et al. PET/CT with Gluc-Lys([18F]FP)-TOCA: correlation between uptake, size and arterial perfusion in somatostatin receptor positive lesions. Eur. J. Nucl. Med. Mol. Imaging 35, 264-272 (2008)
33. Glaser, M. et al. Radiosynthesis and biodistribution of cyclic RGD peptides conjugated with novel [18F]fluorinated aldehyde-containing prosthetic groups. Bioconjug. Chem. 19, 951-957 (2008)
34. Liu, S. et al. 18F-Labeled galacto and PEGylated RGD dimers for PET imaging of ?v?3 integrin expression. Mol. Imaging Biol. 12, 530-538 (2010)
35. Mu, L. et al. In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors. Bioconjug. Chem. 21, 1864-1871 (2010)
36. Honer, M. et al. 18F-Labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors. J. Nucl. Med. 52, 270-278 (2011)
37. Beer, A.J. et al. [18F]Galacto-RGD positron emission tomography for imaging of ?v?3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clin. Cancer Res. 13, 6610-6616 (2007)
38. Doss, M. et al. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans. J. Nucl. Med. 53, 787-795 (2012)
39. Chin, F.T. et al. First experience with clinical-grade [18F]FPP(RGD)2: an automated multi-step radiosynthesis for clinical PET studies. Mol. Imaging Biol. 14, 88-95 (2012)
40. Mittra, E.S. et al. Pilot pharmacokinetic and dosimetric studies of 18F-FPPRGD2: a PET radiopharmaceutical agent for imaging ?v?3 integrin levels. Radiology 260, 182-191 (2011)
41. McParland, B.J. et al. The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers. J. Nucl. Med. 49, 1664-1667 (2008)
42. Kenny, L.M. et al. Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. J. Nucl. Med. 49, 879-886 (2008)
43. Schaefer, N. et al. Comparison of BAY 86-4367, a new F-18 labeled bombesin analog, with F-18-ethyl-choline in recurrent and primary prostate cancer patients. J. Nucl. Med. 52 (suppl. 1): 40 (2011)
44. Wan, W. et al. First experience of 18F-Alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. J. Nucl. Med. 54, 691-698 (2013)
45. Beer, A.J. et al. PET-based human dosimetry of 18F-Galacto-RGD, a new radiotracer for imaging of ?v?3 expression. J. Nucl. Med. 47, 763-769 (2006)
46. Beer, A.J. et al. Patterns of ?v?3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET. J. Nucl. Med. 49, 255-259 (2008)
47. Flavell, R.R. et al. Site-specific 18F-labeling of the protein hormone leptin using a general two-step ligation procedure. J. Am. Chem. Soc. 130, 9106-9112 (2008)
48. Hong, V., Presolski, S.I., Ma, C. &Finn, M.G. Analysis and optimization of copper-catalyzed azide-Alkyne cycloaddition for bioconjugation. Angew. Chem. Int. Ed. 48, 9879-9883 (2009)
49. Hausner, S.H., Carpenter, R.D., Bauer, N. &Sutcliffe, J.L. Evaluation of an integrin ?v?6-specific peptide labeled with [18F]fluorine by copper-free, strain-promoted click chemistry. Nucl. Med. Biol. 40, 233-239 (2013)
50. Selvaraj, R. et al. Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin ?v?3 targeted PET tracer based on a cyclic RGD peptide. Bioorg. Med. Chem. Lett. 21, 5011-5014 (2011)
51. Namavari, M. et al. A novel method for direct site-specific radiolabeling of peptides using [18F]FDG. Bioconjugate Chem. 20, 432-436 (2009)
52. Wuest, F., Hultsch, C., Berndt, M. &Bergmann, R. Direct labeling of peptides with 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) Bioorg. Med. Chem. Lett. 19, 5426-5428 (2009)
53. Hultsch, C., Schottelius, M., Auernheimer, J., Alke, A. &Wester, H.-J. 18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK) Eur. J. Nucl. Med. Mol. Imaging 36, 1469-1474 (2009)
54. Maschauer, S. et al. Labeling and glycosylation of peptides using click chemistry: a general approach to 18F-glycopeptides as effective imaging probes for positron emission tomography. Angew. Chem. Int. Ed. 49, 976-979 (2010)
55. DallAngelo, S. et al. Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of ?v?3 integrin receptor. Org. Biomol. Chem. 11, 4551-4558 (2013)
56. Mueller, K. Inflammations Yin-Yang. Science 339, 155 (2013)
57. Li, Y. et al. 18F-Click labeling of a bombesin antagonist with an alkyne-18F-ArBF3-: in vivo PET imaging of tumors expressing the GRP-receptor. Am. J. Nucl. Med. Mol. Imaging 3, 57-70 (2013)
58. Liu, S., Park, R., Conti, P.S. &Li, Z. Kit like 18F labeling method for synthesis of RGD peptide-based PET probes. Am. J. Nucl. Med. Mol. Imaging 3, 97-101 (2013)
59. Hhne, A. et al. Synthesis, 18F-labeling and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks. Bioconjugate Chem. 19, 1871-1879 (2008)
60. McBride, W.J., Sharkey, R.M. &Goldenberg, D.M. Radiofluorination using aluminum-fluoride (Al18F) EJNMMI Res. 3, 36 (2013)
61. Klepper, F., Jahn, E.-M., Hickmann, V. &Carell, T. Synthesis of the transfer-RNA nucleoside queuosine by using a chiral allyl azide intermediate. Angew. Chem. Int. Ed. 46, 2325-2327 (2007)
62. Sarabia-Garca, F. &Lpez-Herrera, F.J. Studies on the synthesis of tunicamycin. The preparation of 7-deoxy-2-deamino-6-hydroxy tunicamine and related products. Tetrahedron 52, 4757-4768 (1996)